Allergenspezifische Immuntherapie

Zurück zum Zitat Anonymous (2008) für Gesundheit, B., 2008. Verordnung über die Ausdehnung der Vorschriften über die Zulassung der Arzneimittel auf Therapieallergene, die für einzelne Personen auf Grund einer Rezeptur hergestellt werden, sowie über Verfahrensregelungen der staatlichen Chargenprüfung (Therapieallergene-Verordnung). In: I BT (ed), p pp.2177–2178. Anonymous (2008) für Gesundheit, B., 2008. Verordnung über die Ausdehnung der Vorschriften über die Zulassung der Arzneimittel auf Therapieallergene, die für einzelne Personen auf Grund einer Rezeptur hergestellt werden, sowie über Verfahrensregelungen der staatlichen Chargenprüfung (Therapieallergene-Verordnung). In: I BT (ed), p pp.2177–2178.

Zurück zum Zitat Arvidsson MB, Lowhagen O, Rak S (2002) Effect of 2‑year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy. J Allergy Clin Immunol 109:777–783CrossRefPubMed Arvidsson MB, Lowhagen O, Rak S (2002) Effect of 2‑year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy. J Allergy Clin Immunol 109:777–783CrossRefPubMed

Zurück zum Zitat Caraffini S, Assalve D, Stingeni L et al (1995) Allergic contact conjunctivitis and blepharitis from tobramycin. Contact Derm 32:186–187CrossRef Caraffini S, Assalve D, Stingeni L et al (1995) Allergic contact conjunctivitis and blepharitis from tobramycin. Contact Derm 32:186–187CrossRef

Zurück zum Zitat Couroux P, Ipsen H, Stage BS et al (2019) A birch sublingual allergy immunotherapy tablet reduces rhinoconjunctivitis symptoms when exposed to birch and oak and induces IgG(4) to allergens from all trees in the birch homologous group. Allergy 74:361–369CrossRefPubMed Couroux P, Ipsen H, Stage BS et al (2019) A birch sublingual allergy immunotherapy tablet reduces rhinoconjunctivitis symptoms when exposed to birch and oak and induces IgG(4) to allergens from all trees in the birch homologous group. Allergy 74:361–369CrossRefPubMed

Zurück zum Zitat Dhami S, Nurmatov U, Arasi S et al (2017) Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Allergy 72:1597–1631CrossRefPubMed Dhami S, Nurmatov U, Arasi S et al (2017) Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Allergy 72:1597–1631CrossRefPubMed

Zurück zum Zitat Durham SR, Yang WH, Pedersen MR et al (2006) Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 117:802–809CrossRefPubMed Durham SR, Yang WH, Pedersen MR et al (2006) Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 117:802–809CrossRefPubMed

Zurück zum Zitat Fauquert JL, Jedrzejczak-Czechowicz M, Rondon C et al (2017) Conjunctival allergen provocation test : guidelines for daily practice. Allergy 72:43–54CrossRefPubMed Fauquert JL, Jedrzejczak-Czechowicz M, Rondon C et al (2017) Conjunctival allergen provocation test : guidelines for daily practice. Allergy 72:43–54CrossRefPubMed

Zurück zum Zitat Gerth Van Wijk R, Klimek L, Pfaar O (2023) Clinical endpoints in allergen immunotherapy: state of the art 2022. Allergol Select 7:39–46CrossRefPubMedPubMedCentral Gerth Van Wijk R, Klimek L, Pfaar O (2023) Clinical endpoints in allergen immunotherapy: state of the art 2022. Allergol Select 7:39–46CrossRefPubMedPubMedCentral

Zurück zum Zitat Heppt M, Heppt W (2016) Nasaler und konjunktivaler Provokationstest. In: Biedermann T, Heppt W, Renz H, Röcken M (Hrsg) Allergologie. Springer, Berlin, Heidelberg, S 475–481CrossRef Heppt M, Heppt W (2016) Nasaler und konjunktivaler Provokationstest. In: Biedermann T, Heppt W, Renz H, Röcken M (Hrsg) Allergologie. Springer, Berlin, Heidelberg, S 475–481CrossRef

Zurück zum Zitat Huang Y, Wang C, Wang X et al (2019) Efficacy and safety of subcutaneous immunotherapy with house dust mite for allergic rhinitis: a meta-analysis of randomized controlled trials. Allergy 74:189–192CrossRefPubMed Huang Y, Wang C, Wang X et al (2019) Efficacy and safety of subcutaneous immunotherapy with house dust mite for allergic rhinitis: a meta-analysis of randomized controlled trials. Allergy 74:189–192CrossRefPubMed

Zurück zum Zitat Khinchi MS, Poulsen LK, Carat F et al (2004) Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 59:45–53CrossRefPubMed Khinchi MS, Poulsen LK, Carat F et al (2004) Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 59:45–53CrossRefPubMed

Zurück zum Zitat Lake IR, Jones NR, Agnew M et al (2017) Climate change and future pollen allergy in Europe. Environ Health Perspect 125:385–391CrossRefPubMed Lake IR, Jones NR, Agnew M et al (2017) Climate change and future pollen allergy in Europe. Environ Health Perspect 125:385–391CrossRefPubMed

Zurück zum Zitat Landeck L, John SM, Geier J (2013) Topical ophthalmic agents as allergens in periorbital dermatitis. Br J Ophthalmol Landeck L, John SM, Geier J (2013) Topical ophthalmic agents as allergens in periorbital dermatitis. Br J Ophthalmol

Zurück zum Zitat Li J, Wu Y, Yang Y et al (2019) The efficacy and safety of two commercial house dust mite extracts for allergic rhinitis: a head-to-head study. Int Forum Allergy Rhinol 9:876–882CrossRefPubMed Li J, Wu Y, Yang Y et al (2019) The efficacy and safety of two commercial house dust mite extracts for allergic rhinitis: a head-to-head study. Int Forum Allergy Rhinol 9:876–882CrossRefPubMed

Zurück zum Zitat Klimek LCV, Werfel T (2018) Weißbuch Allergie in Deutschland. Springer Klimek LCV, Werfel T (2018) Weißbuch Allergie in Deutschland. Springer

Zurück zum Zitat Mahler V, Kleine-Tebbe J, Vieths S (2020) Immunotherapy of allergies: current status. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 63:1341–1356CrossRefPubMedPubMedCentral Mahler V, Kleine-Tebbe J, Vieths S (2020) Immunotherapy of allergies: current status. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 63:1341–1356CrossRefPubMedPubMedCentral

Zurück zum Zitat Mancuso G, Berdondini RM (2008) Occupational conjunctivitis as the sole manifestation of airborne contact allergy to trimethylolpropane triacrylate contained in a UV-cured paint. Contact Derm 59:372–373CrossRef Mancuso G, Berdondini RM (2008) Occupational conjunctivitis as the sole manifestation of airborne contact allergy to trimethylolpropane triacrylate contained in a UV-cured paint. Contact Derm 59:372–373CrossRef

Zurück zum Zitat Mueller A (2022) Allergic conjunctivitis: an update. Handb Exp Pharmacol 268:95–99CrossRefPubMed Mueller A (2022) Allergic conjunctivitis: an update. Handb Exp Pharmacol 268:95–99CrossRefPubMed

Zurück zum Zitat Nolte H, Bernstein DI, Nelson HS et al (2020) Efficacy and safety of ragweed SLIT-tablet in children with allergic rhinoconjunctivitis in a randomized, placebo-controlled trial. J Allergy Clin Immunol Pract 8:2322–2331 e2325CrossRefPubMed Nolte H, Bernstein DI, Nelson HS et al (2020) Efficacy and safety of ragweed SLIT-tablet in children with allergic rhinoconjunctivitis in a randomized, placebo-controlled trial. J Allergy Clin Immunol Pract 8:2322–2331 e2325CrossRefPubMed

Zurück zum Zitat Patel P, Holdich T, Von Fischer Weikersthal-Drachenberg KJ et al (2014) Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen. J Allergy Clin Immunol 133:121–129 e121–122CrossRefPubMed Patel P, Holdich T, Von Fischer Weikersthal-Drachenberg KJ et al (2014) Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen. J Allergy Clin Immunol 133:121–129 e121–122CrossRefPubMed

Zurück zum Zitat Pfaar O, Agache I, De Blay F et al (2019) Perspectives in allergen immunotherapy: 2019 and beyond. Allergy 74:3–25CrossRefPubMed Pfaar O, Agache I, De Blay F et al (2019) Perspectives in allergen immunotherapy: 2019 and beyond. Allergy 74:3–25CrossRefPubMed

Zurück zum Zitat Pfaar O, Ankermann T, Augustin M et al (2022) Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), Society of Pediatric Allergology and Environmental Medicine (GPA), Medical Association of German Allergologists (AeDA), Austrian Society of Allergology and Immunology (OGAI), Swiss Society for Allergology and Immunology (SSAI), German Dermatological Society (DDG), German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), German Society of Pediatrics and Adolescent Medicine (DGKJ), Society of Pediatric Pulmonology (GPP), German Respiratory Society (DGP), German Professional Association of Otolaryngologists (BVHNO), German Association of Paediatric and Adolescent Care Specialists (BVKJ), Federal Association of Pneumologists, Sleep and Respiratory Physicians (BdP), Professional Association of German Dermatologists (BVDD). Allergol Select 6:167–232CrossRefPubMedPubMedCentral Pfaar O, Ankermann T, Augustin M et al (2022) Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), Society of Pediatric Allergology and Environmental Medicine (GPA), Medical Association of German Allergologists (AeDA), Austrian Society of Allergology and Immunology (OGAI), Swiss Society for Allergology and Immunology (SSAI), German Dermatological Society (DDG), German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), German Society of Pediatrics and Adolescent Medicine (DGKJ), Society of Pediatric Pulmonology (GPP), German Respiratory Society (DGP), German Professional Association of Otolaryngologists (BVHNO), German Association of Paediatric and Adolescent Care Specialists (BVKJ), Federal Association of Pneumologists, Sleep and Respiratory Physicians (BdP), Professional Association of German Dermatologists (BVDD). Allergol Select 6:167–232CrossRefPubMedPubMedCentral

Zurück zum Zitat Pfaar O, Demoly P, Gerth Van Wijk R et al (2014) Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI position paper. Allergy 69:854–867CrossRefPubMed Pfaar O, Demoly P, Gerth Van Wijk R et al (2014) Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI position paper. Allergy 69:854–867CrossRefPubMed

Zurück zum Zitat Pfaar O, Urry Z, Robinson DS et al (2012) A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy. Allergy 67:272–279CrossRefPubMed Pfaar O, Urry Z, Robinson DS et al (2012) A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy. Allergy 67:272–279CrossRefPubMed

Zurück zum Zitat Ring J, Beyer K, Biedermann T et al (2021) Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (OGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE). Allergo J Int 30:1–25CrossRefPubMedPubMedCentral Ring J, Beyer K, Biedermann T et al (2021) Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (OGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE). Allergo J Int 30:1–25CrossRefPubMedPubMedCentral

Zurück zum Zitat Roberts G, Pfaar O, Akdis CA et al (2018) EAACI Guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy 73:765–798CrossRefPubMed Roberts G, Pfaar O, Akdis CA et al (2018) EAACI Guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy 73:765–798CrossRefPubMed

Zurück zum Zitat Roseler STM, Baron JM, Hoflich C et al (2020) “New” inhalant plant allergens. Allergol Select 4:1–10CrossRefPubMedPubMedCentral Roseler STM, Baron JM, Hoflich C et al (2020) “New” inhalant plant allergens. Allergol Select 4:1–10CrossRefPubMedPubMedCentral

Zurück zum Zitat Schmid JM, Wurtzen PA, Siddhuraj P et al (2021) Basophil sensitivity reflects long-term clinical outcome of subcutaneous immunotherapy in grass pollen-allergic patients. Allergy 76:1528–1538CrossRefPubMed Schmid JM, Wurtzen PA, Siddhuraj P et al (2021) Basophil sensitivity reflects long-term clinical outcome of subcutaneous immunotherapy in grass pollen-allergic patients. Allergy 76:1528–1538CrossRefPubMed

Zurück zum Zitat Shamji MH, Kappen JH, Akdis M et al (2017) Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI position paper. Allergy 72:1156–1173CrossRefPubMed Shamji MH, Kappen JH, Akdis M et al (2017) Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI position paper. Allergy 72:1156–1173CrossRefPubMed

Zurück zum Zitat Sindher SB, Long A, Acharya S et al (2018) The use of biomarkers to predict aero-allergen and food immunotherapy responses. Clin Rev Allergy Immunol 55:190–204CrossRefPubMedPubMedCentral Sindher SB, Long A, Acharya S et al (2018) The use of biomarkers to predict aero-allergen and food immunotherapy responses. Clin Rev Allergy Immunol 55:190–204CrossRefPubMedPubMedCentral

Zurück zum Zitat Smets K, Werbrouck J, Goossens A et al (2017) Sensitization from ketotifen fumarate in eye drops presenting as chronic conjunctivitis. Contact Derm 76:124–126CrossRef Smets K, Werbrouck J, Goossens A et al (2017) Sensitization from ketotifen fumarate in eye drops presenting as chronic conjunctivitis. Contact Derm 76:124–126CrossRef

Zurück zum Zitat Valsecchi R, Pansera B, Leghissa P et al (1996) Allergic contact dermatitis of the eyelids and conjunctivitis from diclofenac. Contact Derm 34:150–151CrossRef Valsecchi R, Pansera B, Leghissa P et al (1996) Allergic contact dermatitis of the eyelids and conjunctivitis from diclofenac. Contact Derm 34:150–151CrossRef

Zurück zum Zitat Van Hage-Hamsten M, Johansson SG (1992) Storage mites. Exp Appl Acarol 16:117–128CrossRefPubMed Van Hage-Hamsten M, Johansson SG (1992) Storage mites. Exp Appl Acarol 16:117–128CrossRefPubMed

Zurück zum Zitat Van Ketel WG, Melzer-Van Riemsdijk FA (1980) Conjunctivitis due to soft lens solutions. Contact Derm 6:321–324CrossRef Van Ketel WG, Melzer-Van Riemsdijk FA (1980) Conjunctivitis due to soft lens solutions. Contact Derm 6:321–324CrossRef

Zurück zum Zitat Heppt WCB (2011) Praktische Allergologie. ThiemeCrossRef Heppt WCB (2011) Praktische Allergologie. ThiemeCrossRef

Zurück zum Zitat Yukselen A, Kendirli SG, Yilmaz M et al (2013) Two year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing subcutaneous and sublingual immunotherapy. Asian Pac J Allergy Immunol 31:233–241CrossRefPubMed Yukselen A, Kendirli SG, Yilmaz M et al (2013) Two year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing subcutaneous and sublingual immunotherapy. Asian Pac J Allergy Immunol 31:233–241CrossRefPubMed